Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Epilepsy

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 100%Moderate 0 · 0%High 0 · 0%

Somnolence · people with drug‐resistant focal epilepsy

Pregabalin may leads to higher adverse effect: somnolence compared with placebo (low certainty).

1 finding from 1 review

Pregabalin add‐on for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
RR 2.05 [1.49, 2.81]
9 studies · 2663 participants
Low

Somnolence · people with drug‐resistant focal epilepsy

1 finding from 1 review

Pregabalin add‐on for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
1.16 [0.88, 1.53]
3 studies · 1286 participants
Low